M11.852
Other specified crystal arthropathies, left hip
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code M11.852 refers to a specific type of crystal arthropathy affecting the left hip. This condition involves the formation of crystals within the joint, leading to inflammation and joint discomfort. Crystal arthropathies are a group of joint diseases characterized by the deposition of microscopic crystals in the joint tissues. When these crystals accumulate, they can cause sudden and severe episodes of joint pain, swelling, and redness. The term 'other specified' indicates that the condition falls outside the common classifications but still involves crystal deposits that lead to joint issues, particularly in the left hip in this case.
Causes & Symptoms
Clinical Causes: Uric acid crystal deposits, often associated with gout Calcium pyrophosphate crystals, linked to pseudogout Metabolic disorders leading to abnormal crystal formation Chronic joint trauma or injury that facilitates crystal accumulation Genetic predispositions affecting crystal metabolism Dehydration and dietary factors contributing to crystal formation Kidney dysfunction impairing crystal excretion
Key Symptoms: Intense joint pain, often sudden in onset Swelling and warmth around the joint Redness of the overlying skin Reduced joint mobility and stiffness Tenderness upon touching the affected area Possible fever during acute episodes Recurrent flare-ups leading to joint damage over time
Diagnostic & Treatment
Diagnosis Path: Diagnosing other specified crystal arthropathies involves a combination of clinical evaluation and laboratory tests. Key diagnostic steps include: - **Joint Aspiration:** Extracting synovial fluid from the affected joint to look for crystals under a microscope, which helps distinguish between gout and pseudogout. - **Blood Tests:** Measuring serum uric acid levels and other markers of inflammation. - **Imaging Studies:** X-rays, ultrasound, or CT scans to identify joint damage, crystal deposits, or other abnormalities. - **Medical History:** Reviewing past episodes, dietary habits, and genetic factors that may contribute to crystal formation.
Treatment Protocols: Managing other specified crystal arthropathies typically involves reducing inflammation and preventing future attacks. Treatment options include: - **Medications:** - Non-steroidal anti-inflammatory drugs (NSAIDs) to relieve pain and inflammation - Colchicine for acute flare management - Corticosteroids, either oral or injected, for severe cases - Uric acid-lowering therapies for gout-related crystal deposits - **Lifestyle Changes:** - Dietary modifications to reduce purine intake and avoid foods that promote crystal formation - Increasing hydration to help dilute crystal-forming substances - Weight management to reduce joint stress - **Physical Therapy:** Exercises to maintain joint flexibility and strength - **Monitoring and Follow-up:** Regular check-ups to assess joint health and prevent complications
Clinical Advice & FAQs
Billing Guidance
Is M11.852 a billable ICD-10 code?
Yes, M11.852 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M11.852?
Clinical documentation must specify the nature of Other specified crystal arthropathies, left hip and any associated comorbidities for accurate reporting.
Cite this Clinical Reference